Gefitinib Pregnancy and Breastfeeding Warnings
Gefitinib is also known as: Iressa
Gefitinib Pregnancy Warnings
Gefitinib has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of reduced fetal weight, a reduction in the number of offspring born alive, and high neonatal mortality soon after parturition. There are no controlled data in human pregnancy. Gefitinib should only be given during pregnancy when there are no alternatives and benefit outweighs risk.
Women of childbearing potential must be advised to avoid becoming pregnant.
Gefitinib Breastfeeding Warnings
There are no data on the excretion of gefitinib into human milk. Because many drugs are excreted into human milk and because of the potential for serious adverse reactions in nursing infants, women should be advised against breast-feeding while receiving gefitinib therapy.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.